Molecular Therapy
Publisher: Elsevier · ISSN 1525-0016 · 79 articles
-
Development of CRISPR_SCD001, an autologous hematopoietic stem cell gene therapy for sickle cell disease
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Mark DeWitt, Beatriz Campo-Fernandez, Sohini Roy, Alissa L.W. Kleinhenz, Alejandra Davila, Mallory Lennon, Jonnathan T. Vu, Netravathi...
-
C-terminal CD28 phosphorylation, pY218, modulates IL-2 secretion and therapeutic effect of CAR-T cells
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Elena Martinez-Planes, Maria Cecilia Ramello, Miguel G. Fontela, Mohammad-Reza Shokri, Timothy H. Tran, Lancia Darville, John M. Koomen,...
-
DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Shichuan Hu, Gang Shi, Jing Zhao, Xiangyu Long, Liansha Tang, Zhongbing Qi, Xianglin Xu, Ping Cheng, Jiyan Liu
-
Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Junqi Xiang, Jie Xu, Jing Zhu, Bo Yang, Mingling Wan, Jiangyu Cai, Shuying Chen, Yuncheng Wang, Shanrong Yang, Yaokai Wang, Li Lin, Qiqi Zhang,...
-
Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Katie Kubek-Luck, Jason Velazquez, Xiaorui Yao, Joseph Gabriels, Charles Hsu, Sanjay Arora, Lara Bontadelli, Yoann Gilbart, Fumiaki Aihara, Hui...
-
A complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Xueyan Zhang, Xue Zhang, Qiuyu Yang, Bin Kang, Mo Dan, Chunlei Li, Yan Chen, Jianhua Gan, Xiaoye Su
-
Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Linda Mota, David Zhang, Yulieth Soto Ortiz, Federico Zertuche Gonzalez, Eunhee Chung, Caleb Dang, Achraf Noureddine, Eric M. Brey, Maria A....
-
Pan-cancer oncolytic virotherapy through disruption of tumor cell mitochondrial dynamics
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Shufeng Feng, Lu Cui, Yongxin Zhu, Yao Cheng, Dongmei Diao, Xuefeng Li, Huimin Duan, Haixia Zhang, Xiaoxiao Liu, Qing Pan, Fanpu Ji, Yu Zhang,...
-
Pre-clinical validation of AAV gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Rabab Rashwan, Paula I. Fuller-Carter, Xin Ru Lim, Alicia A. Brunet, Annie L. Miller, Yashvi Bhatt, Rebekah James, Denise Anderson, Valentina...
-
Viral gene replication enhances AAV vector quality and reduces manufacturing costs
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Hao Liu, Ailing Du, Nan Liu, Mayank Kapadia, Xiupeng Chen, Jialing Liang, Ji Sun Lee, Jun Xie, Guangping Gao, Dan Wang
-
The DreAM-plus integrative RNA switch enhances transient AAV expression and reduces side effects of gene editing
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Yueyang Zhang, Yuhan Yang, Zhanzhao Liu, Yue Li, Yizhe Xue, Zihan Zhang, Gonglie Chen, Jin Liu, Mengying He, Tian Lu, Yaohua Zhang, Dongyu Zhao,...
-
Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Shahama Taifour, Chee-Wai Wong, Christopher Wallis, Edina Wang, Ash W.J. Tie, Eleanor Woodward, Charlene Waryah, Mahnaz Hosseinpour, Dilys Lam,...
-
Rational and computation-assisted engineering of a compact and efficient CRISPR-Cas12f genome editor
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Jingtong Liu, Shengzhou Wang, Bei Wang, Tonglu Yu, Xuan Liu, Miaomiao Li, Min-Chi Ku, Rui Wang, Renjie Chai, Wei V. Zheng, Yongming Wang
-
Optimization of AsCas12f1-mediated long-term gene repression
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Yangyang Sun, Lingyun Li, Xiangnan Wang, Linxiao Han, Yingdi Zhao, Yuxi Tan, Ying Feng, Wei Qi, Hanhui Ma
-
Targeting EZH2 and EGFR therapeutic vulnerabilities of TNBC with a single chemical entity confers preclinical treatment advantage
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Saumya Ranjan Satrusal, Arpita Banerjee, Arpon Biswas, Gaurava Srivastava, Indranil Chatterjee, Muqtada Ali Khan, Biswajit Mandal, Kiran...
-
Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Kwiwan Jeong, Subin Hong, Pin Liu, Jinbeom Seo, Taegwan Yun, Sun-mi Park, Myung Jin Song, Jung Eun Yang, Eun-Hye Jeong, Byungil Kim, Sungmin...
-
Lineage-specific pulmonary transcriptome landscape of coronavirus infection unveils universal immunotherapy for viral pneumonia
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Ming Zhou, Xuan Liu, Haiqing Xiao, Zhaojie Su, Kun Wu, Longmei Zhang, Xinglin Li, Wanyun Li, Chang Zhang, Hao Li, Baojie Shi, Chaoyang Chen, Nan...
-
ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Ilayda Baydemir, Fabian Nikolka, Özlem Bulut, Anaísa V. Ferreira, Gizem Kilic, Büsra Geckin, Robbin Kramer, Jorge Cuenca-Escalona, Evelien...
-
Healing helminths: A systematic review of the anti-inflammatory and disease-modifying potential of helminth-derived proteins
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Sienna Stucke, Aonghus Feeney, Richard Lalor, Sheila Donnelly, John Pius Dalton, Declan McKernan, Eilís Dowd
-
BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Zhongqiao Lu, Shuizhen Shi, Fan Xia, Adwaid Manu Krishna Chandran, Jonathan Lin, Daniela J. Iniguez, Massoud Motamedi, Hua Liu, Wenbo Zhang
-
MITF-SCD1 lipid metabolic axis prevents ouabain-induced spiral ganglion neuron ferroptosis and hearing loss
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Xue Wang, Fang Chen, Ziji Zhang, Man Zhang, Man Wang, Lei Chen, Anqi Suo, Xugang Zhuang, Tenghan Ling, Renjie Chai, Haibo Wang, Bo Chu, Lei Xu,...
-
Ammonium tetrathiomolybdate improves auditory and vestibular function after gentamicin exposure via the NRF2-GPX4 axis
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Qiong Wu, Minchao Wu, Mingwei Xu, Tianyu Gong, Yuan Yao, Qianqian Zhang, Linrui Chen, Jianhui Qiu, Yulian Jin, Guisheng Zhong, Yu Zhao, Ce...
-
Triple-AAV intein-mediated gene therapy ameliorates dystrophic phenotype in MDC1A mice
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Núria Rafel-Millan, Carles Bayod-Girón, Maria Pallarès-Masmitjà, Cristina Fernández-Avilés, Keilisa Figuereo-Moya, Ángel Edo, Miguel Chillón,...
-
Retraction Notice to: Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Xihe Zhao, Ping Wang, Jing Liu, Jian Zheng, Yunhui Liu, Jiajia Chen, Yixue Xue
-
Retraction Notice to: Recurrent ZNF83-E293VMutationPromotesBladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Zhao J. Lyu, Ying Wang, Jin L. Huang, Miao Chen, Sha Y. Wu, Qian Yan, Yu Zhang, Ying Tang, Chen Jiang, Lei Li, Yi Z. Jia, Yu C. Liu, Hong B....
-
Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease.
Publication date: Available online 6 November 2026 Source: Molecular Therapy Author(s): Panagiotis Tsapogas, Oleksandr Pastukhov, Veronika Doerr, Christin Elke Berger, Morgane Chambovey, Christopher Zala, Davidané Kress, Barbara Zubler,...
-
IL-1β signaling on dendritic cells expands tumor-specific T cells to overcome immune checkpoint blockade resistance
Publication date: Available online 6 November 2026 Source: Molecular Therapy Author(s): Hojae Lee, Gyu-Bum Yeon, Hyunseo An, Jiwon Oh, Zhichen Sun, Xue Wang, Casey Moore, Eun Byeol Ko, Longchao Liu, Chuanhui Han, Sunkyung Kim, Eunae...
-
Biotech news
Publication date: Available online 6 November 2026 Source: Molecular Therapy Author(s):
-
MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris
Publication date: Available online 6 November 2026 Source: Molecular Therapy Author(s): Shirin Emtenani, Sabrina Patzelt, Kiana Zarabadi, Tingyu Yang, Anna M. Sigmund, Maxi Hofrichter, Christian Probst, Jens Waschke, Enno Schmidt
-
Enhanced efficacy of gene therapy using a ubiquitous promoter to treat growth hormone-resistant Laron dwarfism in a mouse model
Publication date: Available online 6 November 2026 Source: Molecular Therapy Author(s): Kian Chuan Sia, Shu Uin Gan, Zhen Ying Fu, John J. Kopchick, Michael J. Waters, Kok-Onn Lee